Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.18% |
| 2 | Consumer Discretionary | 6.93% |
| 3 | Technology | 6.31% |
| 4 | Industrials | 5.82% |
| 5 | Financials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
CALL
Boeing
BA
$167B
| $19K | 0.02% |
115,100
-9,300
| -7% | -$1.58M |
|
802
Boston Properties
BXP
$11B
| $19K | 0.02% |
236,844
-346,595
| -59% | -$30.3M |
|
|
CERN
803
DELISTED
Cerner Corp
CERN
| $19K | 0.02% |
262,533
+122,703
| +88% | +$8.74M |
|
|
STPK.U
804
DELISTED
Star Peak Energy Transition Corp. Units, each consisting of one share of Class A common stock, and o
STPK.U
| $19K | 0.02% |
+1,850,000
| New | +$18.7M |
|
805
TC Energy
TRP
$64.2B
| $19K | 0.02% |
451,035
+67,355
| +18% | +$3.08M |
|
806
Idacorp
IDA
$7.94B
| $18.9K | 0.02% |
236,864
+81,739
| +53% | +$7.2M |
|
|
BERY
807
DELISTED
Berry Global Group, Inc.
BERY
| $18.8K | 0.02% |
423,882
-472,145
| -53% | -$21.6M |
|
808
American Express
AXP
$231B
| $18.7K | 0.02% |
186,988
-63,960
| -25% | -$6.29M |
|
809
Ascendis Pharma A/S
ASND
$16.4B
| $18.7K | 0.02% |
121,338
-86,280
| -42% | -$12.4M |
|
|
KDMN
810
DELISTED
Kadmon Holdings, Inc.
KDMN
| $18.7K | 0.02% |
4,758,388
+2,538,385
| +114% | +$10.7M |
|
|
INAQU
811
DELISTED
INSU Acquisition Corp. II Unit
INAQU
| $18.6K | 0.02% |
+1,800,000
| New | +$18.9M |
|
812
Dropbox
DBX
$7.52B
| $18.6K | 0.02% |
964,088
-1,562,250
| -62% | -$32.5M |
|
813
Fate Therapeutics
FATE
$272M
| $18.5K | 0.02% |
463,946
-676,289
| -59% | -$23.6M |
|
814
BioNTech
BNTX
$27.9B
| $18.5K | 0.02% |
267,730
+99,632
| +59% | +$7.15M |
|
|
FTIVU
815
DELISTED
FinTech Acquisition Corp. IV Unit
FTIVU
| $18.5K | 0.02% |
+1,820,290
| New | +$18.6M |
|
816
MarketAxess Holdings
MKTX
$5.71B
| $18.5K | 0.02% |
38,378
-23,750
| -38% | -$11.7M |
|
817
CALL
Autodesk
ADSK
$53.8B
| $18.5K | 0.02% |
80,000
+56,900
| +246% | +$13.5M |
|
|
ZGNX
818
DELISTED
Zogenix, Inc.
ZGNX
| $18.5K | 0.02% |
1,030,624
+326,775
| +46% | +$8.01M |
|
819
Alaska Air
ALK
$4.61B
| $18.4K | 0.02% |
503,532
+182,642
| +57% | +$6.84M |
|
820
PUT
Sherwin-Williams
SHW
$85B
| $18.4K | 0.02% |
79,200
| – | – |
|
821
Teladoc Health
TDOC
$1.15B
| $18.4K | 0.02% |
83,820
-568,426
| -87% | -$120M |
|
822
CareDx
CDNA
$2.48B
| $18.3K | 0.02% |
483,397
+4,471
| +0.9% | +$151K |
|
823
Envista
NVST
$4.39B
| $18.3K | 0.02% |
739,619
+548,270
| +287% | +$12.6M |
|
824
Castle Biosciences
CSTL
$1.04B
| $18.3K | 0.02% |
354,731
+6,803
| +2% | +$303K |
|
825
KeyCorp
KEY
$23.6B
| $18.2K | 0.02% |
1,529,484
+1,444,045
| +1,690% | +$17.6M |
|
Similar funds
Israel Englander's Q3 2020 Portfolio in Review
As of Q3 2020, Israel Englander held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
By sector, the portfolio is most concentrated in Healthcare at 9.2% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.
- Israel Englander's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
- Israel Englander added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Israel Englander's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Israel Englander fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Israel Englander's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
- Israel Englander opened 989 new positions and closed 724 in Q3 2020.
- Israel Englander's portfolio value fell 100% quarter-over-quarter to $81.2M.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.